Su, Guoqin

Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA

2 papers on CoChat

Most cited papers

Verified
The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
Black, D. M., Reid, I. R., Boonen, S., Bucci-Rechtweg, C., Cauley, J. A., Cosman, F., Cummings, S. R., Hue, T. F., Lippuner, K., Lakatos, P., et al. (2012) · Journal of Bone and Mineral Research
Bone health and osteoporosis researchBone health and treatments
Cited by 700
Verified
Fracture risk and zoledronic acid therapy in men with osteoporosis
Boonen, S., Reginster, J.-Y., Kaufman, J.-M., Lippuner, K., Zanchetta, J., Langdahl, B., Rizzoli, R., Lipschitz, S., Dimai, H. P., Witvrouw, R., et al. (2012) · New England Journal of Medicine
Bone health and osteoporosis researchBone health and treatments
Cited by 359

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free